Table 4.
Patient demographics, histological diagnosis, location of tumor, blood loss, transfusion requirement and surgical time of study group and control group for the entire study population
| S.No |
Study group (embolisation group), n = 26 |
Control group (non-embolisation group), n = 28 |
|||||||||||
| Age/sex | Diagnosis | Site | Embolising agent | Blood loss (mL) | Transfusion (mL) | Surgical time (min) | Age/sex | Diagnosis | Site | Blood loss (mL) | Transfusion (mL) | Surgical time (min) | |
| 1 | 52 M | GCT | LL | PVA + GEL FOAM | 2900 | 1400 | 230 | 10 F | ABC | LL | 1450 | 750 | 170 |
| 2 | 30 M | GCT | LL | PVA + GEL FOAM | 1740 | 700 | 231 | 46 F | GCT | LL | 1300 | 1400 | 240 |
| 3 | 18 M | OB | SPINE | PVA + GEL FOAM | 1650 | 700 | 240 | 58 M | GCT | LL | 1600 | 1450 | 230 |
| 4 | 17 M | ABC | SPINE | PVA + GEL FOAM | 1600 | 700 | 355 | 20 F | ABC | UL | 1800 | 1400 | 195 |
| 5 | 42 M | GCT | LL | PVA + GEL FOAM | 1500 | 700 | 340 | 28 F | OB | SPINE | 2500 | 1750 | 195 |
| 6 | 14 F | ABC | SPINE | PVA + GEL FOAM | 1200 | 700 | 230 | 31 M | GCT | LL | 1250 | 1050 | 220 |
| 7 | 34 M | CS | ILIUM | GEL FOAM | 1900 | 1400 | 450 | 21 M | GCT | LL | 2500 | 1050 | 145 |
| 8 | 39 F | GCT | LL | PVA + GEL FOAM | 1600 | 700 | 240 | 34 M | GCT | SPINE | 2500 | 1400 | 295 |
| 9 | 45 F | GCT | LL | PVA + GEL FOAM | 1300 | 350 | 180 | 34 F | GCT | LL | 1800 | 1400 | 150 |
| 10 | 31 M | GCT | LL | PVA | 250 | 0 | 115 | 60 F | GCT | LL | 1200 | 700 | 150 |
| 11 | 20 F | GCT | UL | PVA + GEL FOAM | 1300 | 700 | 250 | 20 M | GCT | LL | 6000 | 8400 | 450 |
| 12 | 25 F | GCT | SPINE | PVA | 1300 | 700 | 230 | 28 M | OB | SPINE | 1300 | 700 | 230 |
| 13 | 48 M | GCT | SACRUM | PVA | 1400 | 700 | 240 | 30 M | GCT | LL | 2000 | 2100 | 350 |
| 14 | 15 M | GCT | UL | PVA + GEL FOAM | 500 | 350 | 170 | 45 F | GCT | LL | 1500 | 1400 | 225 |
| 15 | 32 F | GCT | LL | PVA + GEL FOAM | 1600 | 700 | 260 | 22 M | GCT | LL | 4300 | 2100 | 315 |
| 16 | 30 F | GCT | UL | PVA | 350 | 0 | 135 | 40 F | GCT | LL | 1800 | 1400 | 245 |
| 17 | 28 F | GCT | LL | PVA + GEL FOAM | 1400 | 700 | 240 | 24 F | GCT | LL | 800 | 700 | 290 |
| 18 | 32 M | GCT | LL | PVA | 400 | 350 | 190 | 16 M | CB | LL | 1400 | 1050 | 185 |
| 19 | 45 F | GCT | UL | PVA | 2100 | 1050 | 245 | 17 M | GCT | UL | 1800 | 700 | 180 |
| 20 | 20 M | GCT | LL | PVA | 600 | 0 | 125 | 22 F | GCT | LL | 1500 | 1050 | 260 |
| 21 | 20 F | GCT | LL | PVA | 800 | 350 | 145 | 34 M | GCT | UL | 900 | 700 | 245 |
| 22 | 82 M | GCT | LL | PVA | 900 | 350 | 155 | 29 F | GCT | LL | 1500 | 1400 | 270 |
| 23 | 15 M | CB | LL | PVA | 750 | 350 | 135 | 26 M | GCT | LL | 1600 | 1050 | 290 |
| 24 | 22 M | GCT | UL | PVA+GEL FOAM | 1800 | 1400 | 230 | 27 F | GCT | LL | 2600 | 2100 | 335 |
| 25 | 52 M | CS | UL | PVA | 500 | 0 | 250 | 18 M | GCT | LL | 3450 | 2450 | 330 |
| 26 | 42 F | GCT | UL | PVA | 300 | 0 | 140 | 23 F | GCT | UL | 2600 | 2050 | 285 |
| 27 | 21 F | GCT | LL | 2100 | 1400 | 245 | |||||||
| 28 | 24 M | GCT | LL | 1900 | 1400 | 290 | |||||||
GCT: Giant cell tumor; ABC: Aneurysmal bone cyst; OB: Osteoblastoma; CS: Chondrosarcoma; UL: Upper limb; LL: Lower Limb.